The Current State of Molecular Testing and Predictive Biomarkers in Gastrointestinal Malignancies

In this engaging satellite symposium expert faculty discuss current best practice for molecular testing of biomarkers to guide treatment decisions for patients with GI malignancies.

Share

Program Content

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Array BioPharma

Bayer Healthcare Pharma

Merck Sharp & Dohme Corp.